From Genesis to Execution

Genesis is an early stage investor in medical device technology. We are differentiated through our deep level of engagement in delivering value through all stages of the commercialization process. This is accomplished by leveraging the time, talent, and financial resources of the Genesis Innovation Group Portfolio.

Genesis

Step 1:

This is where we find and create the concepts that represent the beginnings of solutions to unsolved problems.

Through the smart deployment of talent and resources, we confirm or query whether further investment is a great opportunity.

Deploy

Step 2:

Launching a company isn’t easy.

Fortunately, we have the talent, experience, and know-how to turn fully developed innovations into valuable assets.

Cultivate

Step 3:

Great ideas are just the beginning.

Further investment in the best of our innovations and findings at the early stages can lead to outsized returns due to our highly operational engagement.

With more than 200 patents and innovations among its founders, Genesis Innovations Group is a leader in medical device development and commercialization.

CEO
Rob Ball
CEO
VICE PRESIDENT, FINANCE & OPERATIONS
Matt Ahearn
VICE PRESIDENT, FINANCE & OPERATIONS
VICE PRESIDENT, SALES & MARKETING
David Blue
VICE PRESIDENT, SALES & MARKETING
VICE PRESIDENT, RESEARCH & DEVELOPMENT
Don Running
VICE PRESIDENT, RESEARCH & DEVELOPMENT
VICE PRESIDENT, SUPPLY CHAIN & QUALITY
Jeff Ondrla
VICE PRESIDENT, SUPPLY CHAIN & QUALITY
MEDICAL DIRECTOR
R. SEAN CHURCHILL, MD
MEDICAL DIRECTOR

cultivate(MD)

cultivate(MD) is an innovative new model for medical technology investment. It drives maximum value, while minimizing capital input.

The cultivate(MD) model is already yielding a harvest, with multiple products entering the market.

Learn More >>>

cultivate post

Portfolio Companies

Genesis Innovation Group is continuously seeking and investigating medical device technologies where our team can complement the creation of value. We are focused on early stage where our team can add value through addition of technical competence, talented team members, and financial resources.

Embody, Inc.
safkan-logo-genesis
SafKan
SpinTech
MEDICAL INGENUITIES
HAPPE Spine
imascap genesis portfolio2
Imascap SAS
iMAGEN genesis portfolio
iMAGEN
Magnesium Development Company genesis portfolio
Magnesium Development Company
shoulder innovations genesis
Shoulder Innovations

Building Deep Relationships

Built on trust, with a long history of successful ventures

Jean Chaoui PhDCEO

Imascap SAS

Genesis played an integral role in developing the strategy for my company. Together with additional investment of time, talent, and money by Genesis, Imascap has grown beyond my expectations.

Mike DeVriesChief Investment Officer

Wakestream Ventures

Wakestream has invested along side Genesis in two of their portfolio companies because we have come to appreciate the depth of experience of the talent at Genesis and their highly innovative approach to business.

Stephen Gunther, MD

Charlottesville, VA

I sought to leverage the value of my IP for years and struggled to get traction. Genesis engaged my project and within a year they did everything they said they would do, and the result was everything I hoped.

Chip CorriganCEO

Medical Ingenuities

One of the best compliments I can say about Genesis is they have done every aspect of medical startup business, and succeeded at it, multiple times. Their professionalism throughout the vetting process was so far superior to any other group we had worked with. Genesis’ unique approach to investing comes from wearing every hat in the process, allowing them to know exactly where you are, where you want to go, and how to get there. It has been a pleasure working with them.

Dr. Ryan RoederFounder and Inventor

HAPPE Spine

After being here (2019 The State of Spine Surgery Think Tank) I’m even more glad to have partnered with Genesis. Your connections, experience, and overall perspective is perfect.

If you are interested in learning more about future investment opportunities, or becoming a strategic partner with us in this trillion dollar healthcare economy, please connect with us.

Request Information
Section subtitle

Latest News

OMTEC 2019 Rob Ball
News

Rob Ball – Keynote Panelist at OMTEC 2019

Rob Ball, CEO of Genesis Innovation Group will be a Keynote Panelist at OMTEC 2019. Event Information State and Future of the Orthopedic Industry: Device Executive Perspective Wednesday, June 12, …